Search Results - "de Kleijn, Ester D"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C by Zeerleder, Sacha, Stephan, Femke, Emonts, Marieke, de Kleijn, Ester D, Esmon, Charles T, Varadi, Katalin, Hack, Cornelis Erik, Hazelzet, Jan A

    Published in Critical care medicine (01-12-2012)
    “…OBJECTIVE:Cell death leading to circulating nucleosomes and histones is a critical step in the pathogenesis of sepsis and contributes to lethality. Activated…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Serum lipids and disease severity in children with severe meningococcal sepsis by Vermont, Clementien L, den Brinker, Marieke, Kâkeci, Nimet, de Kleijn, Ester D, de Rijke, Yolanda B, Joosten, Koen F. M, de Groot, Ronald, Hazelzet, Jan A

    Published in Critical care medicine (01-07-2005)
    “…OBJECTIVE:To evaluate the role of cholesterol and lipoproteins in children with severe meningococcal sepsis. DESIGN:Retrospective observational study…”
    Get full text
    Journal Article
  4. 4

    Prevention of Meningococcal Serogroup B Infections in Children: A Protein-Based Vaccine Induces Immunologic Memory by de Kleijn, Ester D., de Groot, Ronald, Lafeber, Arianne B., Labadie, Jerry, van Limpt, Cees J. P., Visser, John, Berbers, Guy A. M., van Alphen, Loek, Rümke, Hans C

    Published in The Journal of infectious diseases (01-07-2001)
    “…Immunologic memory against meningococci was studied in 177 children (100 children were 10–11 years old and 77 were 5–6 years old) 2.5 years after vaccination…”
    Get full text
    Journal Article
  5. 5

    CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity by Vermont, Clementien L, Hazelzet, Jan A, de Kleijn, Ester D, van den Dobbelsteen, Germie P J M, de Groot, Ronald

    Published in Critical care (London, England) (01-02-2006)
    “…Chemokines are a superfamily of small peptides involved in leukocyte chemotaxis and in the induction of cytokines in a wide range of infectious diseases…”
    Get full text
    Journal Article
  6. 6

    Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age by de Kleijn, Ester D, de Groot, Ronald, Labadie, Jerry, Lafeber, Arianne B, van den Dobbelsteen, Germie, van Alphen, Loek, van Dijken, Harry, Kuipers, Betsy, van Omme, Gijs-Willem, Wala, Mayke, Juttmann, Ricardo, Rümke, Hans C

    Published in Vaccine (14-02-2000)
    “…To study the reactogenicity and immunogenicity of a hexavalent meningococcal outer-membrane-vesicle vaccine (OMV), two different dosages of this vaccine (7.5…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Endothelial Protein C Activation in Meningococcal Sepsis by Piette, W W, Lentz, S R

    Published in The New England journal of medicine (13-12-2001)
    “…To the Editor: In the August 9 issue, Faust et al. 1 reported that the level of endothelial expression of thrombomodulin and the endothelial protein C receptor…”
    Get full text
    Journal Article
  9. 9

    Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations by de Kleijn, E D, de Groot, R, Lafeber, A B, Labadie, J, van Limpt, K C, Visser, J, Berbers, G A, van Alphen, L, Rümke, H C

    Published in Vaccine (08-12-2000)
    “…The safety and immunogenicity of two PorA-based meningococcal outer membrane vesicle (OMV) vaccines against the P1.4 serosubtype adsorbed with AlPO(4) or…”
    Get full text
    Journal Article
  10. 10
  11. 11